Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients-Reference-Cited by-同舟云学术

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients

Published:2019-12-20 Issue:12 Volume:14 Page:e0226853
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Papadopoulou Eirini^ORCID,Tsoulos Nikolaos,Tsantikidi Katerina,Metaxa-Mariatou Vasiliki,Stamou Pinelopi Eleftheria,Kladi-Skandali Athina,Kapeni Evgenia,Tsaousis Georgios,Pentheroudakis George,Petrakis Dimitrios,Lampropoulou Dimitra Ioanna,Aravantinos Gerasimos,Varthalitis Ioannis,Kesisis George,Boukovinas Ioannis,Papakotoulas Pavlos,Katirtzoglou Nikolaos,Athanasiadis Elias,Stavridi Flora,Christodoulou Christos,Koumarianou Anna,Eralp Yeşim,Nasioulas George

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?;S Garinet;J Clin Med,2018

2. Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine;S Coco;Curr Drug Targets,2015

3. Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA;JC Thompson;Clin Cancer Res,2016

4. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer;KM Kruglyak;Adv Exp Med Biol,2016

5. The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies;P Zhang;Int J Genomics,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group;Cancers;2024-09-09

2. Optimising primary molecular profiling in non-small cell lung cancer;PLOS ONE;2024-07-31

3. Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3;Journal of Thoracic Oncology;2024-07

4. NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers;The Journal of Liquid Biopsy;2024-06

5. Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2024-01